GlassScriptPhysician profile
Melody Hu
NPI 1982744769
$3,149.16
in general payments reported to CMS, 2019-2025
30 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $428 · 2021: $215 · 2022: $558 · 2023: $323 · 2024: $505 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $494.72 | 2024-2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $430.18 | 2020-2025 | Relistor |
| Medtronic USA, INC. | $352.74 | 2019-2020 | |
| Abbvie INC. | $184.08 | 2021-2024 | |
| Nevro Corp. | $182.43 | 2019-2024 | Senza |
| Mml US, INC. | $144.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $141.42 | 2025 | Wainua |
| Scilex Pharmaceuticals INC. | $140.01 | 2019-2024 | Ztlido |
| Abbott Laboratories | $138.43 | 2023-2025 | Eterna, Octrode, Proclaim |
| Relievant Medsystems, INC. | $102.15 | 2022 | |
| Impel Pharmaceuticals INC. | $94.19 | 2022-2023 | Trudhesa |
| Biodelivery Sciences International, INC. | $77.94 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $76.19 | 2020-2024 | Belbuca |
| Boston Scientific Corporation | $72.79 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Grt US Holding, INC. | $66.37 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $60.00 | 2023 | Aponvie |
| Amgen INC. | $55.64 | 2022 | |
| Pfizer INC. | $43.50 | 2023-2025 | |
| Lundbeck LLC | $42.99 | 2025 | Vyepti |
| Medtronic, INC. | $41.45 | 2023 | Synchromedii, Intellis Adaptivestim |
| Azurity Pharmaceuticals, INC. | $38.57 | 2023-2024 | Horizant, Horizant |
| Vertex Pharmaceuticals Incorporated | $27.80 | 2024 | |
| Lilly USA, LLC | $25.57 | 2021 | |
| Electronic Waveform Lab, INC. | $22.72 | 2020 | |
| Stimwave Technologies Incorporated | $20.39 | 2020 | |
| Ibsa Pharma INC. | $16.78 | 2021 | |
| Radius Health, INC. | $15.49 | 2021 | |
| Prescient Lab Services, LLC | $14.78 | 2025 | Avertd Biofilmchip Microarray Magazine, Avertd Amplification Mix, Avertd Intellipac Reagent Module |
| Biohaven Pharmaceuticals, INC. | $13.04 | 2021 | |
| Almatica Pharma LLC | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.